Jennifer Berres insider trades: HCA Healthcare (HCA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jennifer reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | HCA | ↓ Sell | 8,020 | $514.58 | $4.1M | Direct | Feb 12, 2026 (1d) |
| Feb 14, 2025 | HCA | ↓ Sell | 9,533 | $322.59 | $3.1M | Direct | Feb 18, 2025 (4d) |
| Feb 7, 2023 | HCA | ↓ Sell | 4,000 | $255.23 | $1.0M | Direct | Feb 9, 2023 (2d) |
| May 13, 2022 | HCA | ↓ Sell | 2,358 | $218.87 | $516K | Direct | May 17, 2022 (4d) |
| Feb 19, 2021 | HCA | ↓ Sell | 6,692 | $176.05 | $1.2M | Direct | Feb 22, 2021 (3d) |
| Nov 5, 2020 | HCA | ↓ Sell | 3,472 | $139.19 | $483K | Direct | Nov 9, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HCA insiders
Open-market trades in the last 12 months
About Jennifer Berres's insider trades
Jennifer Berres is SVP & Chief Human Res. Officer at HCA Healthcare (HCA). Since Nov 5, 2020, Jennifer has reported no open-market purchases and 6 sales worth $10.4M on SEC Form 4. In the last 12 months: 1 sale ($4.1M).
Their filings also include grants and awards (14 filings), shares withheld for taxes (10 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.